OPCH - Option Care Health Inc Stock Price, Fair Value and News

30.23USD-0.09 (-0.30%)Market Closed

Market Summary

USD30.23-0.09

Market Closed

-0.30%

OPCH Stock Price

View Fullscreen

OPCH RSI Chart

OPCH Valuation

Market Cap

5.3B

Price/Earnings (Trailing)

19.27

Price/Sales (Trailing)

1.19

EV/EBITDA

12.92

Price/Free Cashflow

30.76

OPCH Price/Sales (Trailing)

OPCH Profitability

Operating Margin

89.07%

EBT Margin

8.15%

Return on Equity

19.08%

Return on Assets

8.39%

Free Cashflow Yield

3.25%

OPCH Fundamentals

OPCH Revenue

Revenue (TTM)

4.4B

Rev. Growth (Yr)

12.82%

Rev. Growth (Qtr)

1.93%

OPCH Earnings

Earnings (TTM)

272.7M

Earnings Growth (Yr)

14.24%

Earnings Growth (Qtr)

-21.66%

Breaking Down OPCH Revenue

Last 7 days

0.8%

Last 30 days

-3.9%

Last 90 days

-6.8%

Trailing 12 Months

10.6%

How does OPCH drawdown profile look like?

OPCH Financial Health

Current Ratio

1.77

Debt/Equity

0.74

Debt/Cashflow

0.2

OPCH Investor Care

Buy Backs (1Y)

3.31%

Diluted EPS (TTM)

1.53

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	4.4B	0	0	0
2023	4.0B	4.1B	4.2B	4.3B
2022	3.6B	3.7B	3.8B	3.9B
2021	1.8B	1.9B	2.7B	3.4B
2020	2.5B	2.8B	2.3B	1.7B
2019	2.0B	2.0B	2.1B	2.3B
2018	1.1B	1.3B	1.6B	1.9B
2017	914.9M	900.6M	874.7M	817.2M
2016	976.3M	961.9M	939.2M	935.6M
2015	945.7M	962.5M	978.2M	982.2M
2014	809.8M	867.6M	908.4M	922.7M
2013	688.0M	704.4M	724.7M	769.5M
2012	579.3M	603.6M	640.2M	662.6M
2011	461.7M	492.6M	523.6M	554.5M
2010	1.3B	1.4B	1.5B	430.7M
2009	1.4B	1.4B	1.4B	1.3B
2008	1.2B	1.3B	1.4B	1.4B
2007	0	0	0	1.2B
1997	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Option Care Health Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 01, 2024	bodem barbara w.	acquired	-	-	1,731	-
Apr 01, 2024	wright norman l.	acquired	-	-	1,731	-
Mar 09, 2024	whitworth luke	sold (taxes)	-44,402	32.34	-1,373	chief operating officer
Feb 28, 2024	bavaro michael	sold	-62,944	31.7259	-1,984	chief human resources officer
Feb 26, 2024	kraemer harry m jansen jr	bought	1,104,350	31.5529	35,000	-
Feb 23, 2024	shapiro michael h.	sold (taxes)	-809,514	32.24	-25,109	chief financial officer
Feb 23, 2024	whitworth luke	sold (taxes)	-251,408	32.24	-7,798	chief operating officer
Feb 23, 2024	whitworth luke	sold (taxes)	-18,215	32.24	-565	chief operating officer
Feb 23, 2024	grashoff christopher l.	sold (taxes)	-6,996	32.24	-217	chief growth officer
Feb 23, 2024	rademacher john charles	sold (taxes)	-3,199,880	32.24	-99,252	chief executive officer

Which funds bought or sold OPCH recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 07, 2024	Swiss National Bank	reduced	-1.33	-210,813	11,732,300	0.01%
May 07, 2024	OPPENHEIMER ASSET MANAGEMENT INC.	added	8.58	141,564	1,890,980	0.03%
May 07, 2024	ASSETMARK, INC	added	16.75	597,170	4,275,440	0.01%
May 07, 2024	SUSQUEHANNA INTERNATIONAL GROUP, LLP	reduced	-37.36	-1,103,200	1,828,130	-%
May 07, 2024	ClariVest Asset Management LLC	sold off	-100	-752,870	-	-%
May 07, 2024	Illinois Municipal Retirement Fund	unchanged	-	-2,000	540,000	0.01%
May 07, 2024	SEI INVESTMENTS CO	reduced	-6.93	-1,366,240	17,230,600	0.03%
May 07, 2024	Arizona State Retirement System	reduced	-3.19	-61,341	1,632,730	0.01%
May 07, 2024	NEW YORK STATE COMMON RETIREMENT FUND	reduced	-4.37	-464,000	9,216,000	0.01%
May 06, 2024	NEW YORK LIFE INVESTMENT MANAGEMENT LLC	reduced	-2.55	-19,317	628,104	0.01%

Are Funds Buying or Selling OPCH?

Are funds buying OPCH calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own OPCH

No. of Funds

Unveiling Option Care Health Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	11.08%	19,626,205	SC 13G/A
Jan 23, 2024	blackrock inc.	11.9%	21,132,010	SC 13G/A
Sep 11, 2023	vanguard group inc	10.09%	18,142,964	SC 13G/A
Jun 12, 2023	fmr llc	-	0	SC 13G/A
Jun 12, 2023	walgreens boots alliance, inc.	0.0%	0	SC 13D/A
Mar 03, 2023	walgreens boots alliance, inc.	6.0%	10,771,926	SC 13D/A
Feb 14, 2023	price t rowe associates inc /md/	1.4%	2,469,612	SC 13G/A
Feb 09, 2023	fmr llc	-	0	SC 13G/A
Feb 09, 2023	vanguard group inc	8.53%	15,524,268	SC 13G/A
Jan 23, 2023	blackrock inc.	10.9%	19,772,386	SC 13G/A

Recent SEC filings of Option Care Health Inc

View All Filings

Date Filed	Form Type	Document
Apr 23, 2024	10-Q	Quarterly Report
Apr 23, 2024	3	Insider Trading
Apr 23, 2024	8-K	Current Report
Apr 03, 2024	DEFA14A	DEFA14A
Apr 03, 2024	DEF 14A	DEF 14A
Apr 03, 2024	ARS	ARS
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Mar 14, 2024	8-K	Current Report
Mar 12, 2024	4	Insider Trading

Peers (Alternatives to Option Care Health Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	463.9B	371.6B	10.35%	2.61%	20.73	1.25	14.64%	11.24%
CI	98.7B	206.0B	-2.97%	32.18%	25.6	0.48	12.55%	-43.95%
HCA	81.0B	66.7B	-5.69%	12.88%	14.81	1.21	9.59%	-4.59%
CVS	68.9B	360.9B	-26.25%	-21.54%	9.41	0.19	9.07%	78.49%
CNC	40.5B	155.5B	3.95%	12.19%	14.8	0.26	6.34%	84.42%
DVA	11.9B	12.3B	1.61%	34.91%	14.61	0.97	5.77%	58.74%
UHS	11.4B	14.7B	-1.27%	18.38%	13.95	0.78	7.99%	19.23%
MID-CAP
CHE	8.6B	2.3B	-8.25%	4.64%	30.5	3.77	5.96%	18.29%
ACHC	6.1B	3.0B	-12.48%	-3.87%	-542.08	2.05	10.92%	-104.06%
AMN	2.3B	3.8B	2.67%	-35.23%	10.84	0.6	-27.73%	-52.50%
AMEH	2.1B	1.4B	-9.72%	19.70%	34.78	1.52	21.19%	34.42%
SMALL-CAP
ADUS	1.8B	1.1B	5.80%	29.14%	26.69	1.61	11.45%	30.74%
BKD	1.4B	3.0B	1.30%	77.47%	-7.77	0.44	4.98%	4.88%
BEAT	54.0M	-	-4.65%	-8.89%	-3.69	-	-	-12.94%
AMS	19.4M	21.3M	3.37%	9.25%	36.46	0.91	8.00%	-62.25%

Option Care Health Inc News

Latest updates

Option Care Health Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	1.9%	1,146	1,124	1,093	1,069	1,016	1,027	1,021	981	916	927	892	860	759	141	127	741	705	721	616	497	476
Cost Of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	127	121
Gross Profit	-3.5%	239	247	254	251	229	231	218	217	201	212	203	199	165	184	174	166	158	176	138	101	98.00
Operating Expenses	4.2%	169	163	173	168	162	163	157	158	149	151	150	151	136	139	140	143	149	162	149	109	93.00
S&GA Expenses	4.7%	155	148	158	154	148	148	142	142	134	137	135	134	120	123	123	125	129	144	133	99.00	83.00
EBITDA Margin	-2.7%	0.11*	0.11*	0.11*	0.11*	0.08*	0.08*	0.08*	0.08*	0.08*	0.07*	0.09*	0.11*	-	-	-	-	-	-	-	-	-
Interest Expenses	6.2%	13.00	12.00	12.00	13.00	14.00	15.00	14.00	13.00	12.00	14.00	16.00	17.00	19.00	24.00	25.00	31.00	28.00	30.00	22.00	12.00	11.00
Income Taxes	-43.9%	12.00	22.00	14.00	41.00	15.00	17.00	13.00	14.00	11.00	-28.48	3.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	4.00	-5.42	-1.42
Earnings Before Taxes	-27.8%	57.00	79.00	70.00	156	54.00	65.00	52.00	48.00	41.00	47.00	39.00	33.00	-1.58	18.00	2.00	-	-	-38.91	-	-14.01	-10.27
EBT Margin	-2.2%	0.08*	0.08*	0.08*	0.08*	0.05*	0.05*	0.05*	0.05*	0.04*	0.03*	0.03*	0.03*	-	-	-	-	-	-	-	-	-
Net Income	-21.7%	45.00	57.00	56.00	114	39.00	48.00	39.00	34.00	30.00	75.00	35.00	32.00	-2.86	18.00	2.00	-7.67	-19.91	-15.81	-42.79	-13.60	-3.71
Net Income Margin	-0.9%	0.06*	0.06*	0.06*	0.06*	0.04*	0.04*	0.05*	0.05*	0.05*	0.04*	0.03*	0.03*	-	-	-	-	-	-	-	-	-
Free Cashflow	-340.0%	-74.60	31.00	53.00	162	84.00	25.00	80.00	100	27.00	51.00	46.00	70.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	1.0%	3,250	3,217	3,244	3,321	3,130	3,113	3,073	2,986	2,878	2,791	2,786	2,719	2,640	2,647	2,668	2,626	2,613	2,590	2,582	601	597
Current Assets	3.2%	1,130	1,094	1,116	1,198	1,030	994	952	877	806	710	811	736	665	657	676	638	601	559	545	178	171
Cash Equivalents	-36.2%	220	344	386	441	298	294	255	204	146	119	201	158	109	99.00	140	118	77.00	67.00	53.00	47.00	38.00
Inventory	-11.7%	242	274	251	263	250	224	236	232	217	183	190	174	174	159	155	149	139	116	109	28.00	27.00
Net PPE	0.3%	121	121	108	107	106	108	96.00	105	109	112	107	111	116	121	113	118	126	133	132	27.00	28.00
Goodwill	0%	1,540	1,540	1,540	1,541	1,534	1,533	1,533	1,512	1,479	1,478	33.00	1,429	1,429	1,429	1,429	1,429	1,428	1,426	1,419	632	-
Liabilities	1.4%	1,820	1,795	1,804	1,846	1,780	1,727	1,736	1,701	1,657	1,615	1,689	1,662	1,622	1,632	1,675	1,758	1,742	1,683	1,660	676	657
Current Liabilities	3.0%	637	618	624	668	619	565	587	555	508	460	486	460	420	434	433	395	379	330	320	116	116
Long Term Debt	0.0%	1,056	1,057	1,057	1,057	1,058	1,058	1,059	1,059	1,059	1,060	1,118	1,119	1,121	1,124	1,172	1,285	1,286	1,286	1,266	519	507
LT Debt, Current	0%	6.00	6.00	6.00	6.00	6.00	6.00	6.00	6.00	6.00	6.00	12.00	12.00	12.00	9.00	9.00	9.00	9.00	9.00	7.00	-	-
LT Debt, Non Current	0.0%	1,056	1,057	1,057	1,057	1,058	1,058	1,059	1,059	1,059	1,060	1,118	1,119	1,121	1,115	1,163	1,275	1,276	1,277	1,259	-	-
Shareholder's Equity	0.5%	1,429	1,422	1,440	1,475	1,350	1,386	1,337	1,285	1,222	1,176	1,097	1,057	1,018	1,016	993	868	870	907	922	584	597
Retained Earnings	9.8%	502	458	400	344	230	190	143	104	70.00	40.00	-35.60	-71.08	-102	-100	-117	-119	-111	-91.95	-76.14	-787	-771
Additional Paid-In Capital	0.1%	1,206	1,204	1,198	1,188	1,181	1,177	1,172	1,168	1,143	1,139	1,135	1,133	1,130	1,129	1,129	1,009	1,009	1,008	1,008	614	616
Accumulated Depreciation	0.5%	124	124	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	76.00	104
Shares Outstanding	-0.4%	174	175	177	180	181	182	182	181	180	180	180	180	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	5,844	-	-	-	4,018	-	-	-	2,452	-	-	-	473	-	-	-	337	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-235.0%	-68,784	50,969	61,038	169,536	89,752	43,455	87,138	104,273	32,681	65,310	51,225	73,654	18,380	25,664	48,338	34,987	18,403	22,897	-5,836	13,326	9,080
Share Based Compensation	26.9%	9,605	7,571	9,235	7,685	5,988	4,202	4,005	4,398	4,178	3,329	2,516	2,525	1,205	332	1,170	661	757	272	2,745	569	584
Cashflow From Investing	63.1%	-5,820	-15,781	-14,316	-20,649	-5,760	-3,626	-34,474	-64,593	-5,359	-80,945	-4,936	-22,537	-3,123	-14,004	-3,602	-3,375	-5,353	-15,142	-704,818	-3,135	-4,731
Cashflow From Financing	36.1%	-49,732	-77,828	-101,399	-5,497	-80,402	-1,111	-1,242	18,766	-1,145	-65,798	-2,959	-2,953	-5,160	-52,442	-22,788	9,243	-2,862	6,512	716,588	-1,038	-3,038
Buy Backs	-46.7%	40,050	75,153	100,108	-	75,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

OPCH Income Statement

2024-03-31

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
NET REVENUE	$ 1,146,052	$ 1,015,848
COST OF REVENUE	907,552	786,843
GROSS PROFIT	238,500	229,005
OPERATING COSTS AND EXPENSES:
Selling, general and administrative expenses	154,742	147,866
Depreciation and amortization expense	14,728	14,514
Total operating expenses	169,470	162,380
OPERATING INCOME	69,030	66,625
OTHER INCOME (EXPENSE):
Interest expense, net	(13,202)	(13,834)
Equity in earnings of joint ventures	1,125	1,437
Other, net	2	1
Total other expense	(12,075)	(12,396)
INCOME BEFORE INCOME TAXES	56,955	54,229
INCOME TAX EXPENSE	12,164	15,021
NET INCOME	44,791	39,208
OTHER COMPREHENSIVE INCOME (LOSS), NET OF TAX:
Change in unrealized gain (loss) on cash flow hedges, net of income tax (expense) benefit of $(454) and $1,152, respectively	1,551	(3,443)
OTHER COMPREHENSIVE INCOME (LOSS)	1,551	(3,443)
NET COMPREHENSIVE INCOME	$ 46,342	$ 35,765
EARNINGS PER COMMON SHARE:
Earnings per share, basic (in dollars per share)	$ 0.26	$ 0.22
Earnings per share, diluted (in dollars per share)	$ 0.26	$ 0.21
Weighted average common shares outstanding, basic (in shares)	173,928	181,262
Weighted average common shares outstanding, diluted (in shares)	175,624	182,735

OPCH Balance Sheet

2024-03-31

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
CURRENT ASSETS:
Cash and cash equivalents	$ 219,513	$ 343,849
Accounts receivable, net	573,650	377,658
Inventories	241,948	274,004
Prepaid expenses and other current assets	94,603	98,744
Total current assets	1,129,714	1,094,255
NONCURRENT ASSETS:
Property and equipment, net	120,969	120,630
Operating lease right-of-use asset	87,789	84,159
Intangible assets, net	19,317	20,092
Referral sources, net	307,482	315,304
Goodwill	1,540,246	1,540,246
Other noncurrent assets	44,045	42,349
Total noncurrent assets	2,119,848	2,122,780
TOTAL ASSETS	3,249,562	3,217,035
CURRENT LIABILITIES:
Accounts payable	485,736	426,513
Accrued compensation and employee benefits	42,624	92,508
Accrued expenses and other current liabilities	83,383	75,010
Current portion of operating lease liability	19,209	18,278
Current portion of long-term debt	6,000	6,000
Total current liabilities	636,952	618,309
NONCURRENT LIABILITIES:
Long-term debt, net of discount, deferred financing costs and current portion	1,056,282	1,056,650
Operating lease liability, net of current portion	89,207	85,484
Deferred income taxes	37,884	34,920
Other noncurrent liabilities	89	0
Total noncurrent liabilities	1,183,462	1,177,054
Total liabilities	1,820,414	1,795,363
STOCKHOLDERS’ EQUITY:
Preferred stock; $0.0001 par value; 12,500,000 shares authorized, no shares outstanding as of March 31, 2024 and December 31, 2023	0	0
Common stock; $0.0000 par value: 250,000,000 shares authorized, 183,397,817 shares issued and 173,816,056 shares outstanding as of March 31, 2024; 182,905,559 shares issued and 174,575,537 shares outstanding as of December 31, 2023	18	18
Treasury stock; 9,581,761 and 8,330,022 shares outstanding, at cost, as of March 31, 2024 and December 31, 2023, respectively	(295,396)	(255,107)
Paid-in capital	1,205,693	1,204,270
Retained earnings	502,304	457,513
Accumulated other comprehensive income	16,529	14,978
Total stockholders’ equity	1,429,148	1,421,672
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 3,249,562	$ 3,217,035

About Option Care Health Inc

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and others; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

CEO	Mr. John C. Rademacher
WEBSITE	optioncarehealth.com
INDUSTRY	Healthcare Plans
EMPLOYEES	5597

Option Care Health Inc Frequently Asked Questions

What is the ticker symbol for Option Care Health Inc? What does OPCH stand for in stocks?

OPCH is the stock ticker symbol of Option Care Health Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Option Care Health Inc (OPCH)?

As of Wed May 08 2024, market cap of Option Care Health Inc is 5.25 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of OPCH stock?

You can check OPCH's fair value in chart for subscribers.

What is the fair value of OPCH stock?

You can check OPCH's fair value in chart for subscribers. The fair value of Option Care Health Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Option Care Health Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for OPCH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Option Care Health Inc a good stock to buy?

The fair value guage provides a quick view whether OPCH is over valued or under valued. Whether Option Care Health Inc is cheap or expensive depends on the assumptions which impact Option Care Health Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for OPCH.

What is Option Care Health Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed May 08 2024, OPCH's PE ratio (Price to Earnings) is 19.27 and Price to Sales (PS) ratio is 1.19. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. OPCH PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Option Care Health Inc's stock?

In the past 10 years, Option Care Health Inc has provided 0.006 (multiply by 100 for percentage) rate of return.